Reconstituted High Density Lipoprotein, a Versatile Drug Delivery Nanoplatform for Tumor Therapy
- In: Poster Presentation
- At: Stockholm (Sweden) (2017)
- Type: Poster
- Poster code: P-B-066-Tuesday
- By: WANG, Wei (China Pharmaceutical University, Pharmaceutics, Nanjing, China)
- Co-author(s): Wei Wang: Pharmaceutics, China Pharmaceutical University, Nanjing, China
Fangrong Zhang: Pharmaceutics, China Pharmaceutical University, Nanjing, China
Jianping Zhou: Pharmaceutics, China Pharmaceutical University, Nanjing, China - Abstract:
Backgrounds
Reconstituted high density lipoprotein (rHDL) represents an excellent biomimetic tool for targeted delivery of chemical/biological agents (chemotherapeutics, DNA, siRNAs, photosensitizers, etc.) into various tumor cells. These rHDL nanoparticles offer many advantages for antitumor drug delivery over their native counterparts while.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 28 September 2023